GIVLAARI® (givosiran) is a prescription medicine used to treat acute hepatic porphyria (AHP) in adults. It is an δ-aminolevulinic acid synthase 1 (ALAS1)-directed small interfering RNA (siRNA) that works by targeting the underlying cause of AHP in the liver.
GIVLAARI® (givosiran) is FDA-approved for the treatment of acute hepatic porphyria (AHP) in adults. It can be used to treat all four types of AHP:
The cost of prescription medications can vary depending on your insurance coverage. If you're concerned about the price of your medication:
Remember, many resources exist to help patients access necessary medications. Don't hesitate to ask for help if you're struggling with medication costs. No patient should go without necessary treatment due to financial limitations. If you have questions about financial assistance opportunities, contact a member of our Violet Health team.
GIVLAARI® is given once a month as a subcutaneous injection (under the skin) by a healthcare professional. This means you'll need to visit your healthcare provider's office regularly for treatment. Before your infusion, it is important to drink plenty of water and come to your appointment hydrated.
Common side effects of GIVLAARI® are:
More serious side effects that include medical attention include:
Your comfort during GIVLAARI®infusion therapy at Violet Health is our priority. Our patients enjoy walk-up parking, complimentary entertainment and snacks, and a team of highly trained providers during each treatment. Plus, Violet Health’s evening and weekend hours and convenient city and rural locations make it easier to schedule your appointments.
Violet Health Infusion Centers provides infusion therapy for patients with rare, chronic, or complex conditions in a comfortable, patient-centered atmosphere.
Before you attend your first appointment at Violet Health, please make sure to review the documents below. Please contact us if you have any questions!
Medical Director
Director of Partnerships
Simplify patient referrals and offer advanced treatment options with our infusion partnership program.
There may be a better way to manage your condition – explore infusion therapy.